Oral-Systemic Link: Page 120

CEL-SCI licenses head/neck cancer drug for Croatia, Serbia
By DrBicuspid.com staff writers
CEL-SCI has expanded its licensing agreement with Teva Pharmaceutical Industries for its cancer drug Multikine, CEL-SCI's investigational phase III drug for the treatment of head and neck cancer.
July 19, 2011
Nanoparticles attack head/neck cancer
By DrBicuspid.com staff writers
Using tumor-targeted nanoparticles to deliver high doses of anticancer agents directly to head and neck tumors increases survival while triggering fewer side effects, according to a study in the Journal of Oral and Maxillofacial Surgery.
July 17, 2011
Clinical trial to test new head/neck cancer drug
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration has approved a national clinical trial to study the safety and effectiveness of a drug treatment on patients receiving radiation and chemotherapy for head and neck cancer.
July 14, 2011
OralCDx aids in monitoring leukoplakia
By DrBicuspid.com staff writers
The OralCDx brush test demonstrated high sensitivity and specificity values in diagnosing and monitoring oral leukoplakia, according to a study in Oral Medicine, Oral Pathology and Oral Surgery.
July 14, 2011
Proper denture fit could help prevent dementia
By DrBicuspid.com staff writers
Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision, and hearing, may lower a person's risk for developing dementia, according to a new study.
July 13, 2011
U.S. debates if boys should get HPV vaccine
By Donna Domino
With the alarming rise in oropharyngeal cancer among men being linked to the human papillomavirus (HPV) virus, the U.S. Centers for Disease Control and Prevention is mulling whether to recommend routine HPV vaccination for young boys as well as girls.
July 13, 2011
2011 07 06 16 26 35 958 Boy Vaccine 70
HPV highly prevalent in organ transplant recipients
By DrBicuspid.com staff writers
A new study published in the American Journal of Transplantation reveals an association between certain types of human papillomavirus (HPV) infection and cutaneous squamous cell carcinoma in organ transplant recipients.
July 11, 2011
Canadian firm licenses oral cancer detection technology
By DrBicuspid.com staff writers
Imaging technology provider Verisante Technology has entered into an exclusive agreement to license the worldwide rights for a novel multispectral imaging cancer detection technology with the inventors.
July 11, 2011
Dental implants aid oral cancer patients
By DrBicuspid.com staff writers
Dental implants provide an important alternative in the oral rehabilitation of oral cancer patients, according to a study in the Australian Dental Journal.
July 11, 2011
Sleep apnea may cause blood vessel abnormalities
By DrBicuspid.com staff writers
Obstructive sleep apnea may cause changes in blood vessel function that reduce blood supply to the heart in people who are otherwise healthy, according to new research reported in Hypertension, the journal of the American Heart Association.
July 11, 2011
Gene links craniosynostosis, delayed tooth eruption, extra teeth
By DrBicuspid.com staff writers
Researchers at the University of Helsinki in Finland have described a new, recessively inherited human syndrome featuring craniosynostosis, maxillary hyperplasia, delayed tooth eruption, and extra teeth.
July 11, 2011
Grant awarded for 1st oral bacteria database
By DrBicuspid.com staff writers
A team of researchers at King's College London and the Forsyth Institute have been awarded a follow-on grant by the U.S. National Institute for Dental and Craniofacial Researh to continue their work compiling the first comprehensive list of oral bacterial species.
July 7, 2011
Previous Page
Page 120 of 151
Next Page